Drug Shortage Report for LEVOPHED
Report ID | 60222 |
Drug Identification Number | 02241981 |
Brand name | LEVOPHED |
Common or Proper name | LEVOPHED |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | NOREPINEPHRINE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 10 x 4mL |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-01-04 |
Actual start date | |
Estimated end date | |
Actual end date | 2018-09-19 |
Shortage status | Avoided shortage |
Updated date | 2018-09-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-09-19 | French | Compare |
v7 | 2018-09-19 | English | Compare |
v6 | 2018-09-18 | French | Compare |
v5 | 2018-09-18 | English | Compare |
v4 | 2018-09-15 | English | Compare |
v3 | 2018-09-07 | French | Compare |
v2 | 2018-09-07 | English | Compare |
v1 | 2018-09-07 | English | Compare |
Showing 1 to 8 of 8